Philotypes of intestinal microbiotes in patients with arterial hypertension and abdominal obesity

被引:1
作者
Koval, S. M. [1 ]
Snihurska, I. O. [1 ]
Yushko, K. O. [1 ]
机构
[1] NAMS Ukraine, GI LT Malaya Therapy Natl Inst, Dept Arterial Hypertens & Prevent Its Complicat, Kharkiv, Ukraine
来源
PATHOLOGIA | 2020年 / 03期
关键词
arterial hypertension; abdominal obesity; gut microbiota; phylotypes; GUT MICROBIOTA;
D O I
10.14739/2310-1237.2020.3.221771
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim: to study the content of the main phylotypes of the gut microbiota (GM) (Firmicutes, Bacteroidetes and Actinobacteria) in residents of Ukraine - patients with arterial hypertension (AH), which occurs against the background of abdominal obesity (AO) and metabolic disorders. Materials and methods. 70 patients (residents of Ukraine) with AH stage II, 2-3 degrees (46 patients with AO and 24 with normal body weight (NBW)) were examined. The control group consisted of 20 practically healthy individuals. The survey included standard clinical, laboratory and instrumental methods. The content of the main GM phylotypes was determined by identifying the total bacterial DNA and DNA of Firmicutes, Bacteroidetes and Actinobacteria using the method of quantitative real-time polymerase chain reaction. Statistical analysis of the data was carried out using standard methods using Microsoft Excel 17.0. Results. In patients with AH in combination with AO, residents of Ukraine, significant differences were revealed in the relative content of the main phylotypes of GM, both in comparison with healthy individuals and patients with AH and NBW: a significant increase in the relative content of Firmicutes compared with the control group and a significant increase in the ratio of Firmicutes/Bacteroidetes in comparison with practically healthy individuals and with hypertension patients with NBW. In addition, in AH patients with AO, in contrast to AH patients with NBW, it was found that changes in the GM composition at the level of their main phylotypes are associated with the presence of prediabetes, an insulin resistance (IR) index, and the level of low-density lipoprotein cholesterol in the blood. Conclusions. The results of this study indicate that changes in GM can play a significant role in the pathogenesis of AH and AO in residents of Ukraine.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 28 条
  • [1] Aberrant intestinal microbiota in individuals with prediabetes
    Allin, Kristine H.
    Tremaroli, Valentina
    Caesar, Robert
    Jensen, Benjamin A. H.
    Damgaard, Mads T. F.
    Bahl, Martin I.
    Licht, Tine R.
    Hansen, Tue H.
    Nielsen, Trine
    Dantoft, Thomas M.
    Linneberg, Allan
    Jorgensen, Torben
    Vestergaard, Henrik
    Kristiansen, Karsten
    Franks, Paul W.
    Hansen, Torben
    Backhed, Fredrik
    Pedersen, Oluf
    [J]. DIABETOLOGIA, 2018, 61 (04) : 810 - 820
  • [2] [Anonymous], 2000, World Health Organ Tech Rep Ser, V894, pi
  • [3] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco
    Grant, Peter J.
    Aboyans, Victor
    Bailey, Clifford J.
    Ceriello, Antonio
    Delgado, Victoria
    Federici, Massimo
    Filippatos, Gerasimos
    Grobbee, Diederick E.
    Hansen, Tina Birgitte
    Huikuri, Heikki, V
    Johansson, Isabelle
    Juni, Peter
    Lettino, Maddalena
    Marx, Nikolaus
    Mellbin, Linda G.
    Ostgren, Carl J.
    Rocca, Bianca
    Roffi, Marco
    Sattar, Naveed
    Seferovic, Petar M.
    Sousa-Uva, Miguel
    Valensi, Paul
    Wheeler, David C.
    Piepoli, Massimo Francesco
    Birkeland, Kare, I
    Adamopoulos, Stamatis
    Ajjan, Ramzi
    Avogaro, Angelo
    Baigent, Colin
    Brodmann, Marianne
    Bueno, Hector
    Ceconi, Claudio
    Chioncel, Ovidiu
    Coats, Andrew
    Collet, Jean-Philippe
    Collins, Peter
    Cosyns, Bernard
    Di Mario, Carlo
    Fisher, Miles
    Fitzsimons, Donna
    Halvorsen, Sigrun
    Hansen, Dominique
    Hoes, Arno
    Holt, Richard I. G.
    Home, Philip
    Katus, Hugo A.
    Khunti, Kamlesh
    Komajda, Michel
    Lambrinou, Ekaterini
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 (02) : 255 - 323
  • [4] Human colonic microbiota associated with diet, obesity and weight loss
    Duncan, S. H.
    Lobley, G. E.
    Holtrop, G.
    Ince, J.
    Johnstone, A. M.
    Louis, P.
    Flint, H. J.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (11) : 1720 - 1724
  • [5] Hall ME., 2018, Hypertension: A Companion to Braunwald's Heart Disease, V3rd, P33, DOI DOI 10.1016/B978-0-323-42973-3.00005-6
  • [6] Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies
    Kang, Yongbo
    Cai, Yue
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (02) : 110 - 117
  • [7] The intestinal microbiota and cardiovascular disease
    Katsimichas, Themistoklis
    Antonopoulos, Alexios S.
    Katsimichas, Alexandros
    Ohtani, Tomohito
    Sakata, Yasushi
    Tousoulis, Dimitris
    [J]. CARDIOVASCULAR RESEARCH, 2019, 115 (10) : 1471 - 1486
  • [8] Gut microbiota and cardiovascular disease: opportunities and challenges
    Kazemian, Negin
    Mahmoudi, Morteza
    Halperin, Frank
    Wu, Joseph C.
    Pakpour, Sepideh
    [J]. MICROBIOME, 2020, 8 (01)
  • [9] Koval S, 2019, Georgian Med News, P52
  • [10] Gut microbiota and arterial hypertension (a literature review)
    Koval, S. M.
    Yushko, K. O.
    Snihurska, I. O.
    [J]. ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (04) : 561 - 567